07:00 , Oct 27, 2016 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Neuroendocrine tumors Patient sample and cell culture studies suggest promoting GDPD5 expression or inhibiting GPC6 could help treat neuroblastoma. In patients, high tumor levels of GDPD5 and low tumor levels of GPC6 , a...